Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at three years

BACKGROUND: Alzheimer’s disease (AD) is the most common dementing illness. Development of effective treatments directed at AD requires an early diagnosis. Mild cognitive impairment (MCI) often heralds AD. Thus, characterizing MCI is fundamental to the early diagnosis of AD. PARTICIPANTS: Nineteen MC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pardo, José V., Lee, Joel T., Kuskowski, Michael A., Munch, Kristin R., Carlis, John V., Sheikh, Sohail A., Surerus, Christa, Lewis, Scott M., McCarten, J. Riley, Fink, Howard, McPherson, Susan, Shah, Hemant H., Rottunda, Susan, Dysken, Maurice W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2918397/
https://ncbi.nlm.nih.gov/pubmed/20447873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2009.09.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados